Babylon’s GP at Hand app raises questions over tech tie-ups

LONDON: A doctor app from London-based start-up Babylon has become the test case for tech companies claiming they can cut costs and improve primary care for the UK’s overburdened public health service. With two National Health Service contracts, Babylons’ GP at Hand has attracted more than 51,000 users across London.

But when a £250,000 investigation into Babylon’s partnership with a cash-strapped local health group was published last week, it contained few answers about the safety or cost-effectiveness of its products.

“The study hasn’t commented on its impact on the NHS economy or on the NHS primary care network structure,” said Seth Dassanayake, co-chair of the medical committee in Hammersmith and Fulham that operates Babylon’s GP at Hand app. “The concern is this technology is untested, unproven.”

GP at Hand — which has gained an avowed fan in health secretary Matt Hancock, who is signed up to its services — offers users access to a doctor and medical advice through an automated chatbot and a smartphone-based video consultation service. The app operates through an NHS practice in Hammersmith and Fulham, but allows anyone to register, as long as they live within 40 minutes of one of its five London clinics.

However, the Hammersmith and Fulham clinical commissioning group has racked up a £21.6m funding hole because it has to pay for the care of more than 45,000 patients from outside the area. Less than 10 per cent of GP at Hand’s 51,000 patients live in Hammersmith and Fulham.

At the same time, doctors have complained about its automated system for assessing medical symptoms, saying it can miss signs of serious illness.

Yet the report, which was commissioned by the NHS last year to assess the impact of GP at Hand and carried out by research firm Ipsos Mori, did not include a “comprehensive assessment of the safety and effectiveness of the automated symptom checker”.

The report’s authors said they had “not been able to fully address whether the Babylon GP at Hand model is affordable and sustainable” and that “evidence on the impact of Babylon GP at Hand on the wider health system is limited”.

Because Babylon, which has been looking for $400m of fresh funding, is the focal point of a debate about the integration of private tech companies in state-funded primary care, the Ipsos Mori report has raised concerns about the difficulty of assessing new technologies that the NHS wants to introduce across the country.

There are growing fears that advances are being pushed by a struggling NHS — and trialled on an increasing number of patients — without undergoing thorough risk assessments beforehand. Babylon has not conducted any clinical trials.

“When something goes wrong, whose fault is it?” asked Andrew Goddard, president of the Royal College of Physicians earlier this year. “Is it the software’s fault? Is it Babylon’s fault because they’ve written the software and the software has got it wrong? Is it the patient’s fault because they haven’t answered the questions correctly? Is it the doctor’s fault because they haven’t accepted the limitations of the software?”

He added after the Ipsos Mori report was published: “It is striking how popular the service has been among one part of the population, although not surprising that for many it doesn’t work. We need to look at the long-term effects on the health of a population and the cost-effectiveness.”

When asked about the concerns, an NHS spokesperson said: “The NHS is pushing ahead with new approaches to improve care for patients and support staff, from digital access to GPs to virtual outpatient services in hospitals and the community.” A spokesperson for Babylon said it was “working with independent experts to run clinical trials”.

In February, NHS England lifted a block on Babylon, giving it the green light to expand to Birmingham. GP at Hand had been blocked in the city over fears that patients would not have full access to immunisation and screening services if they deregistered with local doctors, and Paul Jennings, chief executive of Birmingham & Solihull clinical commissioning group, said it should remain blocked until NHS England had conducted a full review. Babylon have not yet set a date for the Birmingham launch.

The Ipsos Mori report said, however, that a national rollout of services such as GP at Hand may require a “fundamental large-scale redesign of primary care services” and “substantial changes in the way in which primary care is funded”.

The report also said GP at Hand could exacerbate inequalities in healthcare because 94 per cent of its users are under the age of 45, “raising the possibility that those with the greatest health needs will benefit least from the mainstreaming of such a model”.

According to guidelines from the National Institute for Healthcare and Excellence, the medicines advisory body, apps such as Babylon must have “evidence to show successful implementation” in the UK health system and “appropriate safeguarding measures”.

Matthew Noble, medical director at Babylon, said the report showed GP at Hand is “loved by all types of patients”. He added: “The findings show Babylon GP at Hand isn’t just of great benefit to patients and GPs, it is also saving the NHS time and money.”

But doctors said the report’s conclusions were inadequate.

“While the report’s authors themselves admit that far more analysis needs to be done to assess this provider — both on clinical safety and effectiveness, and its impact on the way general practice operates and is funded,” said Richard Vautrey, chairman of the British Medical Association. “Ultimately, the NHS must decide what it wants to prioritise, quick access or continuity and quality of care, because one is likely to come at the price of the other.”